Vaccine Reduces Shingles in
Post–Stem-Cell Transplant Patients
Stem-cell transplants are increasingly being used to treat several blood cancers, such as leukemia, multiple myeloma, and lymphoma. One of the greatest barriers, however, is the high rate of shingles development after the procedure, according to a recent study. Researchers determined, however, that the recombinant zoster vaccine could prevent the painful rash in those cancer patients. Here are more details.

No Toddler Health Issues
From Influenza Vaccination
During Pregnancy
Pregnant women and their newborn infants are at especially high risk for influenza, leading to the United States and other countries recommending vaccination for expectant mothers. Immunization rates remain low, however, at least partly because of concerns about longer term health risks in offspring. A new study found no evidence of increased problems up to age 5 years in those children exposed in utero to the 2009 H1N1 “swine flu” vaccine, however. Read more.